Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Continuous Intravenous Analgesia After Thoracic Surgery
ChiCTR2100049293Phase 4Not yet recruiting
- Sponsor
- Jiangqiao Hospital
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in postoperative pain (2 arms), sponsored by Jiangqiao Hospital. Primary endpoint: VAS score. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100049293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049293.